126 related articles for article (PubMed ID: 7342082)
21. Platelet interaction with vascular smooth muscle in synthesis of prostacyclin.
Hechtman DH; Kroll MH; Gimbrone MA; Schafer AI
Am J Physiol; 1991 May; 260(5 Pt 2):H1544-51. PubMed ID: 1903602
[TBL] [Abstract][Full Text] [Related]
22. Preparative HPLC purification of prostaglandin endoperoxides and isolation of novel cyclooxygenase-derived arachidonic acid metabolites.
Hecker M; Hatzelmann A; Ullrich V
Biochem Pharmacol; 1987 Mar; 36(6):851-5. PubMed ID: 3105538
[TBL] [Abstract][Full Text] [Related]
23. The affinities of prostaglandin H2 and thromboxane A2 for their receptor are similar in washed human platelets.
Mayeux PR; Morton HE; Gillard J; Lord A; Morinelli TA; Boehm A; Mais DE; Halushka PV
Biochem Biophys Res Commun; 1988 Dec; 157(2):733-9. PubMed ID: 2974286
[TBL] [Abstract][Full Text] [Related]
24. PGD3 is the mediator of the antiaggregatory effects of the trienoic endoperoxide PGH3.
Whitaker MO; Needleman P; Wyche A; Fitzpatrick FA; Sprecher H
Adv Prostaglandin Thromboxane Res; 1980; 6():301-3. PubMed ID: 6966885
[No Abstract] [Full Text] [Related]
25. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV
Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555
[TBL] [Abstract][Full Text] [Related]
26. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
Hanasaki K; Arita H
Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
[TBL] [Abstract][Full Text] [Related]
27. Platelet membranes, eicosanoid biosynthesis and putative endogenous calcium ionophores.
Carey F; Menashi S; Authi KS; Hack N; Lagarde M; Crawford N
Adv Exp Med Biol; 1985; 192():185-99. PubMed ID: 2422885
[No Abstract] [Full Text] [Related]
28. Role of endothelium in the response to prostaglandin H2 in isolated dog arteries.
Okamura T; Inoue S; Minami Y; Okunishi H; Toda N
Jpn J Pharmacol; 1989 Apr; 49(4):511-21. PubMed ID: 2724690
[TBL] [Abstract][Full Text] [Related]
29. The effect of precursors, products, and product analogs of prostaglandin cyclooxygenase upon iris sphincter muscle.
Crawford CG; van Alphen GW; Cook HW; Lands WE
Life Sci; 1978 Sep; 23(12):1255-62. PubMed ID: 101727
[No Abstract] [Full Text] [Related]
30. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
Mevkh AT; Basevich VV; Varfolomeev SD
Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
[TBL] [Abstract][Full Text] [Related]
31. Endothelin and platelet function.
Ohlstein EH; Storer B; Nambi P; Given M; Lippton H
Thromb Res; 1990 Mar; 57(6):967-74. PubMed ID: 2116686
[TBL] [Abstract][Full Text] [Related]
32. Endothelium-dependent and independent responses to prostaglandin H2 and arachidonic acid in isolated dog cerebral arteries.
Toda N; Inoue S; Bian K; Okamura T
J Pharmacol Exp Ther; 1988 Jan; 244(1):297-302. PubMed ID: 3121847
[TBL] [Abstract][Full Text] [Related]
33. Platelet thromboxane A2/endoperoxide (TXA2/PGH2) receptors in type I diabetes mellitus.
Jaschonek K; Faul C; Weisenberger H; Krönert K; Schröder H; Renn W
Thromb Haemost; 1989 Jun; 61(3):535-6. PubMed ID: 2529665
[No Abstract] [Full Text] [Related]
34. Cell response kinetics: the phenomenon of supercooperativity in aggregation of human platelets.
Vrzheshch PV; Tatarintsev AV; Yershov DE; Varfolomeyev SD
Thromb Res; 1992 Jun; 66(5):537-47. PubMed ID: 1523610
[TBL] [Abstract][Full Text] [Related]
35. The platelet fibrinogen receptor.
Peerschke EI
Semin Hematol; 1985 Oct; 22(4):241-59. PubMed ID: 2996149
[No Abstract] [Full Text] [Related]
36. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.
Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
Br J Pharmacol; 1981 Jul; 73(3):773-8. PubMed ID: 7248665
[TBL] [Abstract][Full Text] [Related]
38. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
39. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1982 Jul; 222(1):276-81. PubMed ID: 7086705
[TBL] [Abstract][Full Text] [Related]
40. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
